Integrated BioPharma (INBP) Short Interest Ratio & Short Volume

Short interest is the volume of Integrated BioPharma shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 6,400 shares of INBP short. Learn More on Integrated BioPharma's current short interest.

Integrated BioPharma saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 6,400 shares, an increase of 23.1% from the previous total of 5,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Integrated BioPharma: Earth Science Tech, Inc. (0.01%), Lexaria Bioscience Corp. (1.84%), OKYO Pharma Limited (1.00%), Precision BioSciences, Inc. (7.26%), Tempest Therapeutics, Inc. (6.72%), Cardio Diagnostics Holdings, Inc. (4.52%), Outlook Therapeutics, Inc. (27.12%), Anebulo Pharmaceuticals, Inc. (0.07%), Incannex Healthcare Inc. (0.21%), Verrica Pharmaceuticals Inc. (6.67%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

Short selling INBP is an investing strategy that aims to generate trading profit from Integrated BioPharma as its price is falling. INBP shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Integrated BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBP, twice per month. The most recent reporting period available is November, 15 2024.